HR 1392/S 1221 - Legislation to ensure payment amounts for drugs and biologicals under Medicare Part B
HR 2939 - Legislation to create a Medicare Oncology Pilot Program
HR 3200 - House Healthcare Reform Bill - Accountable Care Organizations, Medicare Shared Savings Program Average Sale Price
MethodologyHR 2366 - Legislation that requires insurance plans to provide equal coverage of oral chemotherapy drugs relative to I.V.
chemotherapy.
HR 1927 - Legislation to encourage physicians to provide treatment plans to cancer patients.
America's Healthy Future Act - Accountable Care Organizations, Medicare Shared Savings Program, Average Sale Price
Methodology.
2010 Medicare Physician Fee Schedule
Affordable Healthcare for American Act
Patient Protection and Affordable Act
Duration: January 1, 2008
to
July 25, 2011
General Issues: Medicare/Medicaid , Health Issues
Spending: about $1,512,500 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2008: House of Representatives, U.S. Senate, Centers For Medicare and Medicaid Services (CMS), Government Accountability Office (GAO)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2011
US ONCOLOGY in-house lobbying effort was terminated on July 25, 2011
Original Filing: 300407009.xml
Lobbying Issues
HR 1392/S 1221 - Legislation to ensure payment amounts for drugs and biologicals under Medicare Part B
HR 2939 - Legislation to create a Medicare Oncology Pilot Program
HR 3200 - House Healthcare Reform Bill - Accountable Care Organizations, Medicare Shared Savings Program Average Sale Price
MethodologyHR 2366 - Legislation that requires insurance plans to provide equal coverage of oral chemotherapy drugs relative to I.V.
chemotherapy.
HR 1927 - Legislation to encourage physicians to provide treatment plans to cancer patients.
America's Healthy Future Act - Accountable Care Organizations, Medicare Shared Savings Program, Average Sale Price
Methodology.
2010 Medicare Physician Fee Schedule
Affordable Healthcare for American Act
Patient Protection and Affordable Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS) Government Accountability Office (GAO)
Type of Issue
Medicare/Medicaid Health Issues
1st Quarter, 2011
US ONCOLOGY in-house lobbying effort was terminated on May 11, 2011
Original Filing: 300383599.xml
Lobbying Issues
HR 1392/S 1221 - Legislation to ensure payment amounts for drugs and biologicals under Medicare Part B
HR 2939 - Legislation to create a Medicare Oncology Pilot Program
HR 3200 - House Healthcare Reform Bill - Accountable Care Organizations, Medicare Shared Savings Program Average Sale Price
MethodologyHR 2366 - Legislation that requires insurance plans to provide equal coverage of oral chemotherapy drugs relative to I.V.
chemotherapy.
HR 1927 - Legislation to encourage physicians to provide treatment plans to cancer patients.
America's Healthy Future Act - Accountable Care Organizations, Medicare Shared Savings Program, Average Sale Price
Methodology.
2010 Medicare Physician Fee Schedule
Affordable Healthcare for American Act
Patient Protection and Affordable Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS) Government Accountability Office (GAO)
Type of Issue
Medicare/Medicaid Health Issues
1st Quarter, 2011
In Q1, US ONCOLOGY had in-house lobbyists. The report was filed on April 18, 2011.
Original Filing: 300366986.xml
Lobbying Issues
HR 1392/S 1221 - Legislation to ensure payment amounts for drugs and biologicals under Medicare Part B
HR 2939 - Legislation to create a Medicare Oncology Pilot Program
HR 3200 - House Healthcare Reform Bill - Accountable Care Organizations, Medicare Shared Savings Program Average Sale Price
MethodologyHR 2366 - Legislation that requires insurance plans to provide equal coverage of oral chemotherapy drugs relative to I.V.
chemotherapy.
HR 1927 - Legislation to encourage physicians to provide treatment plans to cancer patients.
America's Healthy Future Act - Accountable Care Organizations, Medicare Shared Savings Program, Average Sale Price
Methodology.
2010 Medicare Physician Fee Schedule
Affordable Healthcare for American Act
Patient Protection and Affordable Act
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS) Government Accountability Office (GAO) U.S. House of Representatives U.S. Senate
Lobbying Issues
HR 1392/S 1221 - Legislation to ensure payment amounts for drugs and biologicals under Medicare Part B
HR 2939 - Legislation to create a Medicare Oncology Pilot Program
HR 3200 - House Healthcare Reform Bill - Accountable Care Organizations, Medicare Shared Savings Program Average Sale Price
MethodologyHR 2366 - Legislation that requires insurance plans to provide equal coverage of oral chemotherapy drugs relative to I.V.
chemotherapy.
HR 1927 - Legislation to encourage physicians to provide treatment plans to cancer patients.
America's Healthy Future Act - Accountable Care Organizations, Medicare Shared Savings Program, Average Sale Price
Methodology.
2010 Medicare Physician Fee Schedule
Affordable Healthcare for American Act
Patient Protection and Affordable Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS) Government Accountability Office (GAO)
4th Quarter, 2010
In Q4, US ONCOLOGY had in-house lobbyists. The report was filed on Jan. 20, 2011.
Original Filing: 300349219.xml
Lobbying Issues
HR 1392/S 1221 - Legislation to ensure payment amounts for drugs and biologicals under Medicare Part B
HR 2939 - Legislation to create a Medicare Oncology Pilot Program
HR 3200 - House Healthcare Reform Bill - Accountable Care Organizations, Medicare Shared Savings Program Average Sale Price
MethodologyHR 2366 - Legislation that requires insurance plans to provide equal coverage of oral chemotherapy drugs relative to I.V.
chemotherapy.
HR 1927 - Legislation to encourage physicians to provide treatment plans to cancer patients.
America's Healthy Future Act - Accountable Care Organizations, Medicare Shared Savings Program, Average Sale Price
Methodology.
2010 Medicare Physician Fee Schedule
Affordable Healthcare for American Act
Patient Protection and Affordable Act
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS) Government Accountability Office (GAO) U.S. House of Representatives U.S. Senate
Type of Issue
Medicare/Medicaid Health Issues
3rd Quarter, 2010
In Q3, US ONCOLOGY had in-house lobbyists. The report was filed on Oct. 20, 2010.
Original Filing: 300327698.xml
Lobbying Issues
HR 1392/S 1221 - Legislation to ensure payment amounts for drugs and biologicals under Medicare Part B
HR 2939 - Legislation to create a Medicare Oncology Pilot Program
HR 3200 - House Healthcare Reform Bill - Accountable Care Organizations, Medicare Shared Savings Program Average Sale Price
MethodologyHR 2366 - Legislation that requires insurance plans to provide equal coverage of oral chemotherapy drugs relative to I.V.
chemotherapy
HR 1927 - Legislation to encourage physicians to provide treatment plans to cancer patients.
America's Healthy Future Act - Accountable Care Organizations, Medicare Shared Savings Program, Average Sale Price
Methodology
2010 Medicare Physician Fee Schedule
Affordable Healthcare for American Act
Patient Protection and Affordable Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate Government Accountability Office (GAO) Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
HR 1392/S 1221 - Legislation to ensure payment amounts for drugs and biologicals under Medicare Part B
HR 2939 - Legislation to create a Medicare Oncology Pilot Program
HR 3200 - House Healthcare Reform Bill - Accountable Care Organizations, Medicare Shared Savings Program Average Sale Price
MethodologyHR 2366 - Legislation that requires insurance plans to provide equal coverage of oral chemotherapy drugs relative to I.V.
chemotherapy
HR 1927 - Legislation to encourage physicians to provide treatment plans to cancer patients.
America's Healthy Future Act - Accountable Care Organizations, Medicare Shared Savings Program, Average Sale Price
Methodology
2010 Medicare Physician Fee Schedule
Affordable Healthcare for American Act
Patient Protection and Affordable Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS) Government Accountability Office (GAO)
2nd Quarter, 2010
In Q2, US ONCOLOGY had in-house lobbyists. The report was filed on July 20, 2010.
Original Filing: 300297161.xml
Lobbying Issues
HR 1392/S 1221 - Legislation to ensure payment amounts for drugs and biologicals under Medicare Part B
HR 2939 - Legislation to create a Medicare Oncology Pilot Program
HR 3200 - House Healthcare Reform Bill - Accountable Care Organizations, Medicare Shared Savings Program Average Sale Price
Methodology
HR 2366 - Legislation that requires insurance plans to provide equal coverage of oral chemotherapy drugs relative to I.V.
chemotherapy
HR 1927 - Legislation to encourage physicians to provide treatment plans to cancer patients.
America's Healthy Future Act - Accountable Care Organizations, Medicare Shared Savings Program, Average Sale Price
Methodology
2010 Medicare Physician Fee Schedule
Affordable Healthcare for America Act
Patient Protection and Affordable Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate Government Accountability Office (GAO) Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
HR 1392/S 1221 - Legislation to ensure payment amounts for drugs and biologicals under Medicare Part B
HR 2939 - Legislation to create Medicare Oncology Pilot Program
HR 3200 - House Healthcare Reform Bill - Accountable Care Organizations, Medicare Shared Savings Program, Average Sale Price
MethodologyHR 2366 - Legislation that requires insurance plans to provide equal coverage of oral chemotherapy drugs relative to I.V.
chemotherapy
HR 1927 - Legislation to encourage physicians to provide treatment plans to cancer patients.
America's Healthy Future Act - Accountable Care Organizations, Medicare Shared Savings Program, Average Sale Price
Methodology
2010 Medicare Physician Fee Schedule
Affordable Healthcare for America Act
Patient Protection and Affordable Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS) Government Accountability Office (GAO)
1st Quarter, 2010
In Q1, US ONCOLOGY had in-house lobbyists. The report was filed on April 20, 2010.
Original Filing: 300270767.xml
Lobbying Issues
HR 1392/S 1221 - Legislation to ensure paymount amounts for drugs and biologicals under Medicare Part B
HR 2939 - Legislation to create a Medicare Oncology Pilot Program
HR 3200 - House Healthcare Reform Bill - Accountable Care Organizations, Medicare Shared Savings Program, Average Sale Price
MethodologyAmerica's Healthy Future Act - Accountable Care Organizations, Medicare Shared Savings Program, Average Sale Price
Methodology
2010 Medicare Physician Fee Schedule
Affordable Healthcare for America Act
Patient Protection and Affordable Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate Government Accountability Office (GAO) Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
HR 1392/ S 1221 - Legislation to ensure payment amounts for drugs and biologicals under Medicare Part B
HR 2939 - Legislation to create Medicare Oncology Pilot Program
HR 3200 - House Healthcare Reform Bill - Accountable Care Organizations, Medicare Shared Savings Program, Average Sale Price
MethodologyAmerica's Healthy Future Act - Accountable Care Organizations, Medicare Shared Savings Program, Average Sale Price
Methodology
2010 Medicare Physician Fee Schedule
Affordable Healthcare for America Act
Patient Protection and Affordable Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate Government Accountability Office (GAO) Centers For Medicare and Medicaid Services (CMS)
4th Quarter, 2009
In Q4, US ONCOLOGY had in-house lobbyists. The report was filed on Jan. 20, 2010.
Original Filing: 300244059.xml
Lobbying Issues
HR 1392/S 1221 - Legislation to ensure payment amounts for drugs and biologicals under Medicare Part B
HR 2939 - Legislation to create a Medicare Oncology Pilot Program
HR 3200 - House Healthcare Reform Bill - Accountable Care Organizations, Medicare Shared Savings Program, Average Sale Price
MethodologyAmerica's Healthy Future Act - Accountable Care Organizations, Medicare Shared Savings Program, Average Sale Price
Methodology
2010 Medicare Physician Fee Schedule
Affordable Healthcare for America Act
Patient Protection and Affordable Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate Government Accountability Office (GAO) Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
HR 1392/ S 1221 - Legislation to ensure payment amounts for drugs and biologicals under Medicare Part B
HR 2939 - Legislation to create a Medicare Oncology Pilot Program
HR 3200 - House Healthcare Reform Bill - Accountable Care Organizations, Medicare Shared Savings Program, Average Sale Price
MethodologyAmerica's Healthy Future Act - Accountable Care Organizations, Medicare Shared Savings Program, Average Sale Price
Methodology
2010 Medicare Physician Fee Schedule
Affordable Healthcare for America Act
Patient Protection and Affordable Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS) Government Accountability Office (GAO)
3rd Quarter, 2009
In Q3, US ONCOLOGY had in-house lobbyists. The report was filed on Oct. 20, 2009.
Original Filing: 300218034.xml
Lobbying Issues
HR 1392/ S 1221 - Legislation to ensure payment amounts for drugs and biologicals under Medicare Part B
HR 2939 - Legislation to create a Medicare Oncology Pilot Program
HR 3200 - House Healthcare Reform Bill - Accountable Care Organizations, Medicare Shared Savings Program, Average Sale Price
MethodologyAmerica's Healthy Future Act - Accountable Care Organizations, Medicare Shared Savings Program, Average Sale Price
Methodology
2010 Medicare Physician Fee Schedule
Agencies Lobbied
U.S. House of Representatives U.S. Senate Government Accountability Office (GAO) Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Medicare/Medicaid Health Issues
2nd Quarter, 2009
In Q2, US ONCOLOGY had in-house lobbyists. The report was filed on July 20, 2009.
Original Filing: 300186930.xml
Lobbying Issues
HR 1392/S 1221 - Legislation to ensure payment amounts for drugs and biologicals under Medicare Part B
HR 2939 - Legislation to create a Medicare Oncology Pilot Program
HR 3200 - House Healthcare Reform Bill
Agencies Lobbied
U.S. House of Representatives U.S. Senate Government Accountability Office (GAO)
Type of Issue
Medicare/Medicaid Health Issues
1st Quarter, 2009
In Q1, US ONCOLOGY had in-house lobbyists. The report was filed on April 20, 2009.
Original Filing: 300161793.xml
Lobbying Issues
HR 1392
HR 6331 - The Medicare Improvement for Patients and Providers Act of 2008
HR 1293, S 1338 - The Medicare Imaging Act of 2007
HR 6725 - The Oncology Care Quality Improvement Act of 2008
Agencies Lobbied
U.S. House of Representatives Government Accountability Office (GAO)
Lobbying Issues
HR 1392
HR 6331 - The Medicare Improvement for Patients and Providers Act of 2008
HR 1293, S 1338 - The Medicare Imaging Act of 2007
HR 6725 - The Oncology Care Quality Improvement Act of 2008
Agencies Lobbied
U.S. House of Representatives Government Accountability Office (GAO)
4th Quarter, 2008
In Q4, US ONCOLOGY had in-house lobbyists. The report was filed on Jan. 16, 2009.
Original Filing: 300122509.xml
Lobbying Issues
HR 6331 - The Medicare Improvement for Patients and Providers Act of 2008
Agencies Lobbied
U.S. House of Representatives U.S. Senate Government Accountability Office (GAO)
Type of Issue
Medicare/Medicaid Health Issues
3rd Quarter, 2008
In Q3, US ONCOLOGY had in-house lobbyists. The report was filed on Oct. 20, 2008.
Original Filing: 300104177.xml
Lobbying Issues
HR 6331 - The Medicare Improvement for Patients and Providers Act of 2008
Agencies Lobbied
U.S. House of Representatives U.S. Senate Government Accountability Office (GAO)
Type of Issue
Medicare/Medicaid Health Issues
2nd Quarter, 2008
In Q2, US ONCOLOGY had in-house lobbyists. The report was filed on July 21, 2008.
Original Filing: 300079307.xml
Lobbying Issues
HR 6331- The Medicare Improvement for Patients and Providers Act of 2008
Agencies Lobbied
U.S. House of Representatives U.S. Senate Government Accountability Office (GAO)
Lobbying Issues
HR 6331 - The Medicare Improvement for Patients and Providers Act of 2008
Agencies Lobbied
U.S. House of Representatives U.S. Senate Government Accountability Office (GAO)
1st Quarter, 2008
US ONCOLOGY amended a lobbying report for in-house lobbying in Q12008 on July 21, 2008
Original Filing: 300079391.xml
Lobbying Issues
HR 6331 - The Medicare Improvement for Patients and Providers Act of 2008
Agencies Lobbied
U.S. House of Representatives U.S. Senate Government Accountability Office (GAO)
Type of Issue
Medicare/Medicaid Health Issues
1st Quarter, 2008
In Q1, US ONCOLOGY had in-house lobbyists. The report was filed on April 16, 2008.
Original Filing: 300039368.xml
Lobbying Issues
Medicare Reimbursement
Medicare Program Reform
Agencies Lobbied
Government Accountability Office (GAO)
Type of Issue
Medicare/Medicaid Health Issues
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate